[go: up one dir, main page]

IL232385A0 - שיטות לטיפול שיגדון בתת–אוכלוסיות של חולים - Google Patents

שיטות לטיפול שיגדון בתת–אוכלוסיות של חולים

Info

Publication number
IL232385A0
IL232385A0 IL232385A IL23238514A IL232385A0 IL 232385 A0 IL232385 A0 IL 232385A0 IL 232385 A IL232385 A IL 232385A IL 23238514 A IL23238514 A IL 23238514A IL 232385 A0 IL232385 A0 IL 232385A0
Authority
IL
Israel
Prior art keywords
trating
gout
methods
patient subpopulations
subpopulations
Prior art date
Application number
IL232385A
Other languages
English (en)
Other versions
IL232385A (he
Original Assignee
Metabolex Inc
Cymabay Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolex Inc, Cymabay Therapeutics Inc filed Critical Metabolex Inc
Publication of IL232385A0 publication Critical patent/IL232385A0/he
Publication of IL232385A publication Critical patent/IL232385A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL232385A 2011-11-04 2014-04-30 שימוש בתרכובות הלופנאט או חומצה הלפונית להכנת תרופות לטיפול בהיפראוריצימיה במטופלי במטופלים עם שגדון ,היפראוריצימיה או ליקוי בתפקוד הכליות IL232385A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/059425 WO2013066352A1 (en) 2011-11-04 2011-11-04 Methods for treating gout in patient subpopulations

Publications (2)

Publication Number Publication Date
IL232385A0 true IL232385A0 (he) 2014-06-30
IL232385A IL232385A (he) 2017-10-31

Family

ID=48192536

Family Applications (1)

Application Number Title Priority Date Filing Date
IL232385A IL232385A (he) 2011-11-04 2014-04-30 שימוש בתרכובות הלופנאט או חומצה הלפונית להכנת תרופות לטיפול בהיפראוריצימיה במטופלי במטופלים עם שגדון ,היפראוריצימיה או ליקוי בתפקוד הכליות

Country Status (14)

Country Link
EP (1) EP2775835A4 (he)
JP (1) JP6047172B2 (he)
KR (1) KR101848122B1 (he)
CN (1) CN104066323A (he)
AU (1) AU2011380509B2 (he)
BR (1) BR112014010693A2 (he)
CA (1) CA2859689C (he)
CL (1) CL2014001156A1 (he)
IL (1) IL232385A (he)
MX (1) MX354846B (he)
NZ (1) NZ624714A (he)
SG (1) SG11201402027PA (he)
WO (1) WO2013066352A1 (he)
ZA (1) ZA201403574B (he)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA028495B1 (ru) * 2012-04-13 2017-11-30 Саймабэй Терапьютикс, Инк. Пероральная композиция для лечения подагры на основе (-)-галофената и колхицина
CN104068288B (zh) * 2014-07-25 2016-08-24 许伟琦 一种防尿路结石的饲料添加剂
CN105920022A (zh) * 2016-05-12 2016-09-07 成都易创思生物科技有限公司 一种抗痛风药物复方制剂
EP3701952A4 (en) * 2017-10-26 2021-06-30 Otsuka Pharmaceutical Co., Ltd. INOSITE PHOSPHATE COMPOSITION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250191A (en) * 1978-11-30 1981-02-10 Edwards K David Preventing renal failure
US6262118B1 (en) * 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
AU2008329673C1 (en) * 2007-11-27 2012-10-25 Ardea Biosciences, Inc. Novel compounds and compositions and methods of use

Also Published As

Publication number Publication date
BR112014010693A2 (pt) 2020-11-10
WO2013066352A1 (en) 2013-05-10
IL232385A (he) 2017-10-31
AU2011380509A1 (en) 2014-05-29
ZA201403574B (en) 2015-11-25
NZ624714A (en) 2016-01-29
JP6047172B2 (ja) 2016-12-21
MX354846B (es) 2018-03-22
SG11201402027PA (en) 2014-09-26
EP2775835A1 (en) 2014-09-17
EP2775835A4 (en) 2015-07-29
MX2014005399A (es) 2015-04-08
KR20140123927A (ko) 2014-10-23
AU2011380509B2 (en) 2016-05-19
KR101848122B1 (ko) 2018-04-11
CL2014001156A1 (es) 2015-01-16
CA2859689A1 (en) 2013-05-10
JP2014532759A (ja) 2014-12-08
CN104066323A (zh) 2014-09-24
CA2859689C (en) 2018-05-22

Similar Documents

Publication Publication Date Title
PL2718630T3 (pl) Urządzenie wyświetlające
HK1179074A1 (zh) 設備鏈接
GB201108156D0 (en) Apparatus
EP2758218A4 (en) DISCHARGE ASSISTANCE EQUIPMENT
GB201114594D0 (en) Apparatus
GB201105779D0 (en) Apparatus
EP2669762A4 (en) INFORMATION PROCESSING DEVICE
EP2637017A4 (en) METHOD FOR MEASURING FILLING CAPACITY
EP2682297A4 (en) VEHICLE ACTUATING APPARATUS
TWI563551B (en) Holding device
GB201120321D0 (en) Apparatus
EP2650276A4 (en) PROCESS FOR PRODUCTION OF -FLUOROALCOOL
EP2726839A4 (en) SAMPLER
EP2738081A4 (en) DEVICE FOR PREVENTING THE FLIP OF A LIQUID
EP2715068A4 (en) TBM
GB201210194D0 (en) Labelling method
HK1198114A1 (en) Holding device
GB201104046D0 (en) Apparatus
HK1198979A1 (en) Intra-vehicular information provision device
IL232385A0 (he) שיטות לטיפול שיגדון בתת–אוכלוסיות של חולים
GB201120971D0 (en) Apparatus
GB201221250D0 (en) Information processing device
GB201117604D0 (en) Carrying apparatus
GB201121008D0 (en) Apparatus & method
GB201019076D0 (en) Screenwash recovery apparatus

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed